Platinum ineligibility in squamous cell carcinoma of the head and neck : consensus from Central America and the Caribbean

The high incidence of head and neck cancer in Central America and the Caribbean, together with limitations in the healthcare system for patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN) in this region necessitate a consensus of opinion based on a review of the literature on therapy with cisplatin plus radiation. Such an approach will ensure appropriate selection of patients who can benefit from therapy and reduce the incidence of related adverse events. Therefore, we recorded the opinion of experts in the region in order to identify needs and challenges in the treatment of LA SCCHN.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:17

Enthalten in:

Future oncology (London, England) - 17(2021), 15 vom: 16. Mai, Seite 1963-1971

Sprache:

Englisch

Beteiligte Personen:

Alvarado-Muñoz, Juan F [VerfasserIn]
Falco, Agustín [VerfasserIn]
Morales, Agatha R [VerfasserIn]
Sánchez, Noé C [VerfasserIn]
Reynoso, Giovanni [VerfasserIn]
Barillas, Allan [VerfasserIn]
Moreno, Jairo [VerfasserIn]
López, Kreilin [VerfasserIn]
Prestol, Rogelio [VerfasserIn]
Cabreja, Angela [VerfasserIn]
Nuñez, César [VerfasserIn]

Links:

Volltext

Themen:

Cetuximab
Cisplatin
Head and neck cancer
Journal Article
Platinum toxicity
Q20Q21Q62J

Anmerkungen:

Date Completed 08.11.2021

Date Revised 08.11.2021

published: Print-Electronic

Citation Status MEDLINE

doi:

10.2217/fon-2020-0931

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM321199006